Provided by Tiger Trade Technology Pte. Ltd.

Insulet

131.96
-2.7200-2.02%
Post-market: 131.960.00000.00%19:30 EDT
Volume:1.75M
Turnover:231.19M
Market Cap:9.14B
PE:24.91
High:135.58
Open:135.40
Low:131.24
Close:134.68
52wk High:354.88
52wk Low:126.40
Shares:69.26M
Float Shares:69.07M
Volume Ratio:1.04
T/O Rate:2.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.30
EPS(LYR):3.48
ROE:26.02%
ROA:9.71%
PB:6.43
PE(LYR):37.93

Loading ...

Analysts Are Bullish on Top Healthcare Stocks: Insulet (PODD), Crispr Therapeutics AG (CRSP)

TIPRANKS
·
Jun 04

Insulet director Elizabeth H. Weatherman buys USD 497,490 of common shares

Reuters
·
Jun 04

Insulet Rolls Out Omnipod 5 With Enhanced Algorithm, Abbott Libre 3 Plus Compatibility

MT Newswires Live
·
Jun 03

Insulet to present Omnipod 5 algorithm upgrades at ADA Scientific Sessions

Reuters
·
Jun 03

Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility With Abbott’s Freestyle Libre 3 Plus Sensor

THOMSON REUTERS
·
Jun 03

Insulet Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 02

TD Cowen Adjusts Insulet Price Target to $294 From $379, Maintains Hold Rating

MT Newswires Live
·
Jun 01

A Look At Insulet (PODD) Valuation After Recent Share Price Weakness

Simply Wall St.
·
May 30

These Were the Best and Worst S&P 500 Stocks in May -- Barrons.com

Dow Jones
·
May 30

Insulet Corp. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
May 29

Insulet Is Maintained at Neutral by Citigroup

Dow Jones
·
May 29

US Appeals Court Overturns Insulet's $452 Mln Insulin-Pump Trade Secret Verdict Against Rival Eoflow

THOMSON REUTERS
·
May 28

US court overturns Insulet's $452 mln insulin-pump trade secret verdict against EOFlow

Reuters
·
May 28

Analysts Are Bullish on Top Healthcare Stocks: Insulet (PODD), Privia Health Group (PRVA)

TIPRANKS
·
May 28

Insulet price target lowered to $165 from $175 at Citi

TIPRANKS
·
May 28

Wells Fargo Reaffirms Their Buy Rating on Insulet (PODD)

TIPRANKS
·
May 28

Citigroup Adjusts Price Target on Insulet to $165 From $175, Maintains Neutral Rating

MT Newswires Live
·
May 28

Insulet (PODD) Receives a Sell from Barclays

TIPRANKS
·
May 28

Insulet Corp. Stock Falls 5.1%, Underperforms Peers

Dow Jones
·
May 28

Insulet to present at William Blair Growth Stock Conference

Reuters
·
May 28